PD‐L1‐Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple‐Negative Breast Cancer
Advanced Science · 2025-11 · 12 (41)
DOI: 10.1002/advs.202506841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.08.2025. Verfasst von Manman Tan und 19 weiteren Autor:innen. Beteiligte Einrichtung: MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, 310000, China. Hauptthemen laut MEDLINE: Liposomes, B7-H1 Antigen, Triple Negative Breast Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Natural Science Foundation of China Key Program, National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Peptide‐based therapeutic strategies offer considerable potential for tumor immunotherapy but suffer from poor systemic bioavailability, rapid plasma clearance, and limited tumor‐targeting efficiency. To address these challenges, a biomimetic, photothermal‐responsive liposomal delivery system was developed that enables precise delivery of immunotherapeutic peptides while enhancing the synergistic effects of photothermal therapy. This system enhances peptide stability through fluorination, disrupts post‐translational modifications of PD‐L1, and promotes its degradation, thereby amplifying the anti‐tumor immune response. The carrier core consisted of thermosensitive 1,2‐dipalmitoyl‐sn‐glycero‐3‐phosphocholine (DPPC) liposomes loaded with the low‐toxicity photosensitizer indocyanine green (ICG), which facilitated controlled peptide release via the photothermal effect. Simultaneously, mild photothermal stimulation induced immunogenic cell death (ICD), further strengthening anti‐tumor immunity. To enhance tumor targeting, extend systemic circulation time, and improve drug accumulation at tumor sites, the carrier surface was coated with a platelet membrane, which increased biocompatibility and promoted immune evasion. Notably, in vivo studies demonstrated that the developed bioengineering platform significantly suppressed tumor growth in both solid and diffuse malignant tumors while inducing persistent immune memory, thereby facilitating long‐term anti‐tumor immune responses. Collectively, this approach establishes a novel framework for integrating peptide drug delivery with photothermal therapy, offering a promising strategy for advancing tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, 310000, China.
- Key Laboratory of RNA Science and Engineering, Institute of Biophysics Chinese Academy of Sciences, Beijing, 100101, China.
- Department of Respiratory and Critical Care Medicine, Center for Oncology Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zheji…
- Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China.
- Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310000, China.
- Department of Pharmacology, and Department of Gastroenterology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310000, China.
ORCID-Profile: Aifu Lin
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Natural Science Foundation of China Key Program
- National Science Fund for Distinguished Young Scholars
- "Lingyan" R&D Research and Development Project
- National Key R&D Program of China
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Young Scientists Fund of the National Natural Science Foundation of China
Zitieren
APA
Tan, M., Shi, C., Chi, G., Su, X., Liu, F., Zhu, L., Cheng, G., Chen, X., Yu, M., Chen, Y., Wang, Y., Chen, Y., Yan, S., Wu, W., Yan, Q., Shao, J., Wang, K., Liu, X., Zhou, M., & Lin, A. (2025). PD‐L1‐Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple‐Negative Breast Cancer. Advanced Science, 12(41). https://doi.org/10.1002/advs.202506841
Vancouver
Tan M, Shi C, Chi G, Su X, Liu F, Zhu L, et al. PD‐L1‐Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple‐Negative Breast Cancer. Advanced Science. 2025;12(41). doi:10.1002/advs.202506841
BibTeX
@article{Tan2025,
author = {Tan, Manman and Shi, Chengyu and Chi, Guangyi and Su, Xinwan and Liu, Fangzhou and Zhu, Linyu and Cheng, Guangqian and Chen, Xiangyi and Yu, Meng and Chen, Yijian and Wang, Ying and Chen, Yu and Yan, ShuLing and Wu, Wenfei and Yan, Qingfeng and Shao, Jianzhong and Wang, Kai and Liu, Xiangrui and Zhou, Min and Lin, Aifu},
title = {PD‐L1‐Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple‐Negative Breast Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {41},
doi = {10.1002/advs.202506841}
}
EUVIMED